Dr Lee B Dittrich, MD in Knoxville, TN - Medicare Dermatology

Dr Lee B Dittrich, MD is a medicare enrolled "Dermatology" physician in Knoxville, Tennessee. He went to Wake Forest University School Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Knoxville Dermatology Group Pc and his current practice location is 123 Fox Rd, Knoxville, Tennessee. You can reach out to his office (for appointments etc.) via phone at (865) 690-9467.

Dr Lee B Dittrich is licensed to practice in Tennessee (license number 36383) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1316905862.

Contact Information

	Dr Lee B Dittrich, MD
	123 Fox Rd, Knoxville, TN 37922-3369
	(865) 690-9467
	(865) 637-5057

Physician's Profile

Full Name	Dr Lee B Dittrich
Gender	Male
Speciality	Dermatology
Experience	26 Years
Location	123 Fox Rd, Knoxville, Tennessee
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Lee B Dittrich attended and graduated from Wake Forest University School Of Medicine in 1998

NPI Data:

NPI Number: 1316905862
Provider Enumeration Date: 05/03/2006
Last Update Date: 08/07/2020

Medicare PECOS Information:

PECOS PAC ID: 5395711311
Enrollment ID: I20040909001019

Medical Identifiers

Medical identifiers for Dr Lee B Dittrich such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316905862	NPI	-	NPPES
7120405	Other	TN	AETNA
3874778	Other	TN	BLUE CROSS
Q007919	Medicaid	TN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	36383 (Tennessee)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Knoxville Dermatology Group Pc	8123009636	26

News Archive

Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay

Senate Finance Committee ranking member Chuck Grassley (R-Iowa) on Tuesday said that he intends to introduce legislation that would increase pressure on the boards of directors at not-for-profit hospitals to ensure pay for the facilities' presidents is reasonable, the Boston Globe reports.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

First full face transplant in the U.S. on its way to success

In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.

FDA grants Mederi 510(k) clearance for new MDRF1 radiofrequency generator

Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Lee B Dittrich allows following entities to bill medicare on his behalf.

Entity Name	Knoxville Dermatology Group Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1760419014 PECOS PAC ID: 8123009636 Enrollment ID: O20040528000815

News Archive

Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

First full face transplant in the U.S. on its way to success

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

FDA grants Mederi 510(k) clearance for new MDRF1 radiofrequency generator

Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Lee B Dittrich is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Lee B Dittrich, MD 123 Fox Rd, Knoxville, TN 37922-3369 Ph: (865) 690-9467	Dr Lee B Dittrich, MD 123 Fox Rd, Knoxville, TN 37922-3369 Ph: (865) 690-9467

News Archive

Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

First full face transplant in the U.S. on its way to success

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

FDA grants Mederi 510(k) clearance for new MDRF1 radiofrequency generator

Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator.

Dermatology Doctors in Knoxville, TN

Dr. Drew Wilson Miller, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1928 Alcoa Hwy, Ste 209, Knoxville, TN 37920 Phone: 865-524-2547 Fax: 865-219-5070
Dr. Matthew C Hanggi, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 123 Fox Rd, Knoxville, TN 37922 Phone: 865-690-9467 Fax: 865-637-5057
Elizabeth Brittian Anderson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6516 Kingston Pike, Knoxville, TN 37919 Phone: 865-450-9361 Fax: 865-450-9362
Sandra Vaughn, NP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1928 Alcoa Hwy Ste 209, Knoxville, TN 37920 Phone: 865-524-2547 Fax: 865-524-0224
Anne Elizabeth Allen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6516 Kingston Pike, Knoxville, TN 37919 Phone: 865-450-9361
Mr. Marcus Rene Ortiz Jr., PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1450 Dowell Springs Blvd Ste 210, Knoxville, TN 37909 Phone: 865-524-2547 Fax: 865-205-5601
Dr. Edward John Primka Iii, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1450 Dowell Springs Blvd Ste 210, Knoxville, TN 37909 Phone: 865-524-2547 Fax: 865-205-5601

Dr Lee B Dittrich, MD - Medicare Dermatology in Knoxville, TN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

First full face transplant in the U.S. on its way to success

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

FDA grants Mederi 510(k) clearance for new MDRF1 radiofrequency generator

Medicare Reassignments

Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

First full face transplant in the U.S. on its way to success

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

FDA grants Mederi 510(k) clearance for new MDRF1 radiofrequency generator

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Grassley to introduce bill modifying how 'not-for-profit' hospitals set executive pay

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

First full face transplant in the U.S. on its way to success

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

FDA grants Mederi 510(k) clearance for new MDRF1 radiofrequency generator

Dermatology Doctors in Knoxville, TN